Clinical Study
Multicenter Randomized Trial of 10-French versus 11.5-French Plastic Stents for Malignant Biliary Obstruction
Table 2
Outcomes in patients stented with 10 Fr and 11.5 Fr stents.
| | 10 Fr ()
| 11.5 Fr () | value |
| Technical success | 99.1% (114/115) | 97.4% (116/119) | 0.37 | Baseline bilirubin (mg/dL) | 10.7 ± 6.8 | 12.8 ± 7.6 | 0.03 | Bilirubin decrease (mg/dL) | 8.7 ± 6.1* | 10.6 ± 6.9* | 0.077* | Days to stent failure | 149 | 258 | 0.16 | Stent-related hosp. days (Mean) | 1.6 ± 3.5 | 1.9 ± 3.8 | 0.50 | Stent-related interventions (mean) | 0.74 ± 1.5 | 0.82 ± 1.5 | 0.66 | Median patient survival days | 151 | 206 | 0.20 |
|
|
After adjusting for difference in baseline bilirubin.
|